Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum β-lactamases: a systematic …

KZ Vardakas, GS Tansarli, PI Rafailidis… - Journal of …, 2012 - academic.oup.com
Objectives To study the comparative mortality associated with carbapenems and alternative
antibiotics for the treatment of patients with extended-spectrum β-lactamase (ESBL)-positive …
被引用次数：445 相关文章
[PDF] archive.org

[PDF][PDF] Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum b-lactamases: a …

KZ Vardakas, GS Tansarli, PI Rafailidis… - J Antimicrob …, 2012 - scholar.archive.org
Objectives: To study the comparative mortality associated with carbapenems and alternative
antibiotics for the treatment of patients with extended-spectrum b-lactamase (ESBL)-positive …

Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum β-lactamases: a systematic …

KZ Vardakas, GS Tansarli, PI Rafailidis… - The Journal of …, 2012 - europepmc.org
Objectives To study the comparative mortality associated with carbapenems and alternative
antibiotics for the treatment of patients with extended-spectrum β-lactamase (ESBL)-positive …

[引用][C] Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum-lactamases: a systematic …

KZ Vardakas, GS Tansarli, PI Rafailidis… - Journal of Antimicrobial …, 2012 - cir.nii.ac.jp
Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to
Enterobacteriaceae producing extended-spectrum -lactamases: a systematic review and …

Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum β-lactamases: a systematic …

KZ Vardakas, GS Tansarli… - The Journal of …, 2012 - pubmed.ncbi.nlm.nih.gov
Objectives To study the comparative mortality associated with carbapenems and alternative
antibiotics for the treatment of patients with extended-spectrum β-lactamase (ESBL)-positive …

Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum β-lactamases: a systematic …

KZ Vardakas, GS Tansarli, PI Rafailidis, ME Falagas - 2012 - cabidigitallibrary.org
Objectives: To study the comparative mortality associated with carbapenems and alternative
antibiotics for the treatment of patients with extended-spectrum β-lactamase (ESBL)-positive …

[引用][C] Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum β-lactamases: a …

KZ VARDAKAS, GS TANSARLI… - Journal of …, 2012 - pascal-francis.inist.fr
Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to
Enterobacteriaceae producing extended-spectrum β-lactamases: a systematic review and …
[PDF] academia.edu

[PDF][PDF] Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum b-lactamases: a …

KZ Vardakas, GS Tansarli, PI Rafailidis… - J Antimicrob …, 2012 - academia.edu
Objectives: To study the comparative mortality associated with carbapenems and alternative
antibiotics for the treatment of patients with extended-spectrum b-lactamase (ESBL)-positive …

Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum β-lactamases: a systematic …

KZ Vardakas, GS Tansarli… - Journal of …, 2012 - search.ebscohost.com
Objectives To study the comparative mortality associated with carbapenems and alternative
antibiotics for the treatment of patients with extended-spectrum β-lactamase (ESBL)-positive …

[引用][C] Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum β-lactamases: a …

KZ Vardakas, GS Tansarli… - Journal of …, 2012 - Oxford University Press